Patient

Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model

Leave a Comment / Genetics / By

Myriad Genetics, Inc. Myriad’s MyRisk™ hereditary cancer test with RiskScore® provides personalized breast cancer risk assessment for women of all backgrounds SALT LAKE CITY, 08 Dec. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a …

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model Read More »

Livestock Improvement: How Forward Pack and Sexed Semen Can Boost Genetic Gain | MarketScreener

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model | MarketScreener

Leave a Comment / Genetics / By

Myriad’s MyRisk™ hereditary cancer test with RiskScore® provides personalized breast cancer risk assessment for women of all backgrounds SALT LAKE CITY, 08 Dec. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more …

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model | MarketScreener Read More »

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model

Leave a Comment / Genetics / By

SALT LAKE CITY, 08 Dec. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more accurate predictor of breast cancer risk than a simple standard of care risk assessment. The data was shared …

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model Read More »

WellSpan Health and Helix Announce Partnership to Improve Patient Health Outcomes with New Population Genomics Program

WellSpan Health and Helix Announce Partnership to Improve Patient Health Outcomes with New Population Genomics Program

Leave a Comment / Genetics / By

York, Pennsylvania, Dec. 08 12, 2022 (GLOBE NEWSWIRE) — WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, today announced a partnership to create a comprehensive population genomics program designed to improve health care outcomes. patients by integrating genetic knowledge into clinical care and research. Interested patients can have a DNA …

WellSpan Health and Helix Announce Partnership to Improve Patient Health Outcomes with New Population Genomics Program Read More »

Invitae Releases Data Use Transparency Report, Demonstrating Impact of Patient Data on Genetic Research

Invitae Releases Data Use Transparency Report, Demonstrating Impact of Patient Data on Genetic Research

Leave a Comment / Genetics / By

– Invited to report on the secondary use of patient data, demonstrating the true impact of anonymized patient data on the advancement of precision medicine – – Company Achieves Over 1 Million ClinVar Submissions to Advance Science and Patient Care – SAN FRANCISCO, December 7, 2022 /PRNewswire/ — Invite (NYSE: NVTA), a leading medical genetics …

Invitae Releases Data Use Transparency Report, Demonstrating Impact of Patient Data on Genetic Research Read More »

Genetic testing for epilepsy improves patient outcomes - News Center

Genetic testing for epilepsy improves patient outcomes – News Center

Leave a Comment / Genetics / By

Anne Berg, PhD, assistant professor of neurology in the Division of Epilepsy and Clinical Neurophysiology, was a co-author on the study published in JWADA Neurology. According to a new study published in JAMA Neurology. Genetic causes are responsible for seizures in 30% or more of infants and toddlers and about 10% of adults with epilepsy, …

Genetic testing for epilepsy improves patient outcomes – News Center Read More »